Nami Isooka
Okayama, 7008558, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Rotenone targets midbrain astrocytes to produce glial dysfunction-mediated dopaminergic neurodegeneration.
Journal: Acta neuropathologica communications
Published: February 27, 2025
Central and Enteric Neuroprotective Effects by Eucommia ulmoides Extracts on Neurodegeneration in Rotenone-induced Parkinsonian Mouse.
Journal: Acta medica Okayama
Published: September 19, 2022
Glial Cells as Possible Targets of Neuroprotection through Neurotrophic and Antioxidative Molecules in the Central and Enteric Nervous Systems in Parkinson's Disease.
Journal: Acta medica Okayama
Published: October 27, 2021
Neuroprotective Effects of Anti-high Mobility Group Box-1 Monoclonal Antibody Against Methamphetamine-Induced Dopaminergic Neurotoxicity.
Journal: Neurotoxicity research
Published: June 08, 2021
Chronic Systemic Exposure to Low-Dose Rotenone Induced Central and Peripheral Neuropathology and Motor Deficits in Mice: Reproducible Animal Model of Parkinson's Disease.
Journal: International journal of molecular sciences
Published: April 16, 2020
Effects of maternal bisphenol A diglycidyl ether exposure during gestation and lactation on behavior and brain development of the offspring.
Journal: Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association
Published: January 10, 2020
Dopaminergic neuroprotective effects of rotigotine via 5-HT1A receptors: Possibly involvement of metallothionein expression in astrocytes.
Journal: Neurochemistry international
Published: July 28, 2019
Showing 1-8 of 8
Last Updated: 09/26/2026